Liftstream is an executive search recruitment company in the life sciences sector
Ascendis Pharma Appoints Chief Medical Officer
Ascendis Pharma, a clinical stage biotechnology company based in Copenhagen, and offices in Palo Alto, has appointed Jonathan A. Leff as Chief Medical Officer to replace Acting Chief Medical Officer Michael Beckert. Beckert will continue his consulting role with the company with a focus on leading the company’s European clinical operations.
A Challenging Time for Remuneration Committees with Executive Pay
Author: Anjie Cai Anderson
Wilson’s Board Gets a New Chairman
Wilson Therapeutics has announced that Andrew Kay has been appointed as Chairman of its Board of Directors. The company’s previous Chairman, Hugh Rienhoff, M.D. will continue to advise the company as a consultant.
Genmab and Novo Nordisk in bispecific antibody deal
Genmab A/S (OMX: GEN) announced it has entered an agreement to grant Novo Nordisk commercial licenses to use the DuoBody technology platform to create and develop bispecific antibody candidates for two therapeutic programs. The bispecific antibodies will target a disease area outside of cancer therapeutics. Under the terms of the agreement, Genmab will receive an upfront payment of USD 2 million from Novo Nordisk.
Cortendo joins a rare disease crowd in Ireland
Hans Schikan appointed Chairman of Complix
Complix, a biopharmaceutical company focused on developing a pipeline of transformative protein therapeutics, called Alphabodies™, mainly focused on oncology and autoimmune diseases, today announced the appointment of Hans Schikan as Chairman of its Board of Directors.
Wilson Therapeutics appoints Chief Medical Officer
Fresh from announcing that Hans Schikan, ex-CEO of Prosensa, would be joining the Board of Directors at Wilson Therapeutics, the company have announced the appointment of another Genzyme allumni, Dr. Carl Bjartmar as chief medical officer (CMO). Dr. Bjartmar will report to Jonas Hansson, chief executive officer, and will join the company’s management team.
Moderna Therapeutics partners with Karolinska Institutet
Authored by James Sheppard